Baxter Review

Spectrum Pharmaceuticals Starts Phase 3 Trial

Spectrum Pharmaceuticals a developer of hematology and oncology treatments, said Monday it has enrolled the first patient in a phase 3 trial of Qapzola, a...
Cambrex Q2 Earnings Meet Views as Revenues Miss

Cambrex reported Friday mixed results for Q2 while increasing its adjusted earnings per share guidance for the year. Q2 adjusted EPS was $0.76, up from...
Party City Buys Stake in Print Appeal

Party City Holdco, a vertically integrated party goods company in North America, said it has acquired a 60% interest in Print Appeal, a privately held...
LyondellBasell to Build Plant in Houston

LyondellBasell said pre-market Friday it will construct a propylene oxide (PO) and tertiary butyl alcohol (TBA) plant in the Houston area in Texas, which is...
Integrated Electrical Services Acquires 80% Stake In NEXT Electric

Integrated Electrical Services, a holding company for industrial infrastructure service providers, said it has acquired 80% of the membership interests in NEXT Electric, a Milwaukee,...

Recent Stock Central

Spectrum Pharmaceuticals Starts Phase 3 Trial By Mary Jones | August 14, 2017

Cambrex Q2 Earnings Meet Views as Revenues Miss By Lucy Watters | August 04, 2017

Party City Buys Stake in Print Appeal By Bruce Farrell | July 27, 2017

LyondellBasell to Build Plant in Houston By Bruce Farrell | July 21, 2017

Integrated Electrical Services Acquires 80% Stake In NEXT Electric By Kevin Lester | July 14, 2017

View All Recent Stock Central ≫